Rihim Pharma Consultancy Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.54 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.02 Cr
as on 24-10-2024
- Revenue 24.16%
(FY 2023)
- Profit 10.80%
(FY 2023)
- Ebitda -34.84%
(FY 2023)
- Net Worth 30.71%
(FY 2023)
- Total Assets 19.07%
(FY 2023)
About Rihim Pharma Consultancy
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.54 Cr. The company has closed loans amounting to ₹1.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gautam Kamdar, Nilesh Thosani, and Ratna Thosani serve as directors at the Company.
- CIN/LLPIN
U52100DL2010PTC202258
- Company No.
202258
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rihim Pharma Consultancy Private Limited offer?
Rihim Pharma Consultancy Private Limited offers a wide range of products and services, including Company Law & Labour Law Consultants, Statutory Compliance Services, Legal Drafting & Litigation Services, Affidavit Attestation Service, Medical Consultants & Clinics, Medical Consultancy Services.
Who are the key members and board of directors at Rihim Pharma Consultancy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Kamdar  | Director | 04-May-2010 | Current |
| Nilesh Thosani | Director | 04-May-2010 | Current |
| Ratna Thosani | Director | 04-May-2010 | Current |
Financial Performance of Rihim Pharma Consultancy.
Rihim Pharma Consultancy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.16% increase. The company also saw a substantial improvement in profitability, with a 10.8% increase in profit. The company's net worth Soared by an impressive increase of 30.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rihim Pharma Consultancy?
In 2023, Rihim Pharma Consultancy had a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rihim Pharma International LlpActive 10 years 4 monthsGautam Kamdar and Nilesh Thosani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Sep 2023 | ₹4.70 M | Open |
Axis Bank Limited Creation Date: 29 Jun 2021 | ₹7.99 M | Open |
Others Creation Date: 21 Sep 2019 | ₹0.85 M | Open |
How Many Employees Work at Rihim Pharma Consultancy?
Rihim Pharma Consultancy has a workforce of 7 employees as of Apr 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rihim Pharma Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rihim Pharma Consultancy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
